JP2021520415A5 - - Google Patents

Info

Publication number
JP2021520415A5
JP2021520415A5 JP2021503713A JP2021503713A JP2021520415A5 JP 2021520415 A5 JP2021520415 A5 JP 2021520415A5 JP 2021503713 A JP2021503713 A JP 2021503713A JP 2021503713 A JP2021503713 A JP 2021503713A JP 2021520415 A5 JP2021520415 A5 JP 2021520415A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
isotope
solvate
hydrate
salt
Prior art date
Application number
JP2021503713A
Other languages
English (en)
Japanese (ja)
Other versions
JP7402857B2 (ja
JPWO2019195634A5 (https=
JP2021520415A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/025910 external-priority patent/WO2019195634A1/en
Publication of JP2021520415A publication Critical patent/JP2021520415A/ja
Publication of JP2021520415A5 publication Critical patent/JP2021520415A5/ja
Publication of JPWO2019195634A5 publication Critical patent/JPWO2019195634A5/ja
Application granted granted Critical
Publication of JP7402857B2 publication Critical patent/JP7402857B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021503713A 2018-04-04 2019-04-04 オピオイド受容体モジュレーター、およびそれに関連する生成物ならびに方法 Active JP7402857B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862652819P 2018-04-04 2018-04-04
US62/652,819 2018-04-04
US201962792754P 2019-01-15 2019-01-15
US62/792,754 2019-01-15
PCT/US2019/025910 WO2019195634A1 (en) 2018-04-04 2019-04-04 Opioid receptor modulators and products and methods related thereto

Publications (4)

Publication Number Publication Date
JP2021520415A JP2021520415A (ja) 2021-08-19
JP2021520415A5 true JP2021520415A5 (https=) 2022-04-11
JPWO2019195634A5 JPWO2019195634A5 (https=) 2022-04-11
JP7402857B2 JP7402857B2 (ja) 2023-12-21

Family

ID=66223867

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021503713A Active JP7402857B2 (ja) 2018-04-04 2019-04-04 オピオイド受容体モジュレーター、およびそれに関連する生成物ならびに方法

Country Status (7)

Country Link
US (2) US20210147343A1 (https=)
EP (1) EP3774722B1 (https=)
JP (1) JP7402857B2 (https=)
CN (1) CN112867705B (https=)
AU (1) AU2019247842B2 (https=)
CA (1) CA3096059A1 (https=)
WO (1) WO2019195634A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2019247842B2 (en) 2018-04-04 2023-08-31 Epiodyne, Inc. Opioid receptor modulators and products and methods related thereto
CN112159401B (zh) * 2019-11-05 2022-06-03 中国人民解放军军事科学院军事医学研究院 偏向性激动剂及其医药用途
EP3964497A1 (en) * 2020-09-04 2022-03-09 Friedrich-Alexander-Universität Erlangen-Nürnberg Substituted vicinal diamine compounds and their use in the treatment, amelioration or prevention of pain
TW202304869A (zh) 2021-04-05 2023-02-01 美商艾碧奧戴股份有限公司 類鴉片受體調節劑
CN117425644A (zh) * 2021-04-05 2024-01-19 埃皮欧黛公司 阿片样物质受体调节剂

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ210669A (en) 1983-12-27 1988-05-30 Syntex Inc Benzoxazin-4-one derivatives and pharmaceutical compositions
JPH05194406A (ja) 1991-11-12 1993-08-03 Yoshitomi Pharmaceut Ind Ltd 新規アミド化合物
IL115420A0 (en) * 1994-09-26 1995-12-31 Zeneca Ltd Aminoheterocyclic derivatives
SE9600769D0 (sv) 1996-02-28 1996-02-28 Astra Ab Compounds useful as analgesic
AU4674797A (en) 1996-10-22 1998-05-15 Ortho Pharmaceutical Corporation Phenylalaninol derivatives for the treatment of central nervous system disorders
US6900228B1 (en) 1998-03-10 2005-05-31 Research Triangle Institute Opiate compounds, methods of making and methods of use
EP1055665B1 (en) 1999-05-28 2003-10-22 Pfizer Products Inc. 3-(3-Hydroxyphenyl)-3-amino-propionamide derivatives
AU2001268951A1 (en) 2000-07-07 2002-01-21 Novo-Nordisk A/S Modulators of protein tyrosine phosphatases (ptpases)
DE10252666A1 (de) 2002-11-11 2004-08-05 Grünenthal GmbH N-Piperidyl-cyclohexan-Derivate
WO2005009315A1 (fr) 2003-06-27 2005-02-03 Applications Technologiques Avancees, A.T.A. Caisson de confinement ou d'isolement d'un nouveau type
WO2005063704A1 (ja) 2003-12-25 2005-07-14 Ono Pharmaceutical Co., Ltd. アゼチジン環化合物およびその医薬
EP1598341A1 (en) 2004-05-21 2005-11-23 Santhera Pharmaceuticals (Deutschland) Aktiengesellschaft DPP-IV inhibitors
EP1604662A1 (en) 2004-06-08 2005-12-14 Santhera Pharmaceuticals (Deutschland) Aktiengesellschaft 1-[(3R)-Amino-4-(2-fluoro-phenyl)-butyl]-pyrrolidine-(2R)-carboxylic acid benzyl amine derivatives and related compounds as dipeptidyl peptidase IV (DPP-IV) inhibitors for the treatment of type 2 diabetes mellitus
WO2007076423A2 (en) 2005-12-22 2007-07-05 Smithkline Beecham Corporation INHIBITORS OF Akt ACTIVITY
US7807704B2 (en) 2006-03-30 2010-10-05 Chemocentryx, Inc. Bicyclic, nitrogen-containing compounds modulating CXCR4 and/or CCXCKR2
KR20080071476A (ko) 2007-01-30 2008-08-04 주식회사 엘지생명과학 신규한 디펩티딜 펩티데이즈 iv(dpp-iv) 저해제
GB0813740D0 (en) 2008-07-28 2008-09-03 Angeletti P Ist Richerche Biologica Therapeutic compounds
CN101823987B (zh) 2009-03-06 2014-06-04 中国科学院上海药物研究所 一类新的dpp-ⅳ抑制剂及其制备方法和用途
GB0919426D0 (en) 2009-11-05 2009-12-23 Glaxosmithkline Llc Novel compounds
CA2787037C (en) 2010-02-24 2018-04-10 Research Triangle Institute Arylpiperazine opioid receptor antagonists
EP2632897B1 (en) 2010-10-29 2014-10-01 Merz Pharma GmbH & Co. KGaA Indole derivatives and process for their preparation
WO2013006734A1 (en) 2011-07-05 2013-01-10 St. Jude Children's Research Hospital Substituted 4-phenoxyphenol analogs as modulators of proliferating cell nuclear antigen activity
CA2840317C (en) 2011-07-13 2016-11-01 Pfizer Limited Enkephalin analogues
WO2013033310A1 (en) 2011-08-31 2013-03-07 Theodore Mark Kamenecka Modulators of rev-erb
WO2013068467A1 (en) 2011-11-09 2013-05-16 Grünenthal GmbH Substituted pyrazolyl-based carboxamide and urea derivatives bearing a phenyl moiety substituted with a co-containing group as vanilloid receptor ligands
WO2016067143A1 (en) * 2014-10-28 2016-05-06 Pfizer Inc. N-(2-alkyleneimino-3-phenylpropyl)acetamide compounds and their use against pain and pruritus via inhibition of trpa1 channels
US10702498B2 (en) * 2015-07-09 2020-07-07 The Regents Of The University Of California MU opioid receptor modulators
US10053465B2 (en) 2015-08-26 2018-08-21 Incyte Corporation Pyrrolopyrimidine derivatives as TAM inhibitors
EP3565543A4 (en) * 2017-01-06 2020-10-14 The Regents of The University of California MU TYPE OPIOID RECEIVER MODULATORS
EP3668852A1 (en) 2017-08-17 2020-06-24 The Regents of The University of California Mu opioid receptor modulators
AU2019247842B2 (en) 2018-04-04 2023-08-31 Epiodyne, Inc. Opioid receptor modulators and products and methods related thereto

Similar Documents

Publication Publication Date Title
JP2021520415A5 (https=)
JP2024050527A5 (https=)
JP2019529490A5 (https=)
JPWO2022216971A5 (https=)
JP2020510091A5 (https=)
JP2019527203A5 (https=)
JP2017504576A5 (https=)
JP2021512109A5 (https=)
JP2018531218A5 (https=)
JPWO2020086616A5 (https=)
JP2013545791A5 (https=)
JP2006524222A5 (https=)
JPS58185553A (ja) α−保護されたオキシイミノ−β−ケト−γ−ハロゲノ酪酸類
AR081426A1 (es) Derivados de pirazol inhibidores del receptor sigma
JP2020535165A5 (https=)
JP2020521766A5 (https=)
JP2018532784A5 (https=)
JP2020508327A5 (https=)
JP2013542267A5 (https=)
JP2020111571A5 (https=)
JP2016503778A5 (https=)
JPWO2021030555A5 (https=)
JP2008525400A5 (https=)
JP2015502371A5 (https=)
JP2017513852A5 (https=)